The Food and Drug Administration rejected Moderna’s application for its mRNA-based flu vaccine, the drugmaker said Tuesday ...
The Food and Drug Administration rejected Moderna's new flu shot. This raises questions about what it means for the future of vaccine development.
The head of the agency’s vaccine division, Vinay Prasad, has overruled pushback from career staffers.
America’s drug safety agency declined to review a next-gen flu vaccine that uses the same tech as the coronavirus shots ...
The Food and Drug Administration on Wednesday defended its rejection of Moderna’s mRNA-based flu vaccine application, saying the company’s clinical trial design put patients at risk ...
The vaccine maker’s shots involve the successful Covid vaccines’ RNA technology. Health Secretary Robert F. Kennedy Jr. has ...
Federal officials on Wednesday cast blame on Moderna as they stood by the Food and Drug Administration’s controversial ...
Opinion
4dOpinion
Clinical Trials Show Moderna's New mRNA Flu Vaccine Is Safe and Effective. FDA Won't Even Consider It.
This week, vaccine manufacturer Moderna revealed that Vinaya Prasad, the top vaccine regulator at the Food and Drug Administration (FDA)—which is a part of HHS— declined to even consider the safety ...
By Mariam Sunny and Michael Erman Feb 13 (Reuters) - Moderna said it is looking for growth overseas after the U.S. FDA ...
The 2024-2025 flu season resulted in 266 pediatric deaths, with 90% of the children who died being eligible for a flu vaccine ...
At issue with Moderna's mRNA flu shot is communication from CBER to Moderna suggesting that the company’s vaccine be compared ...
FDA refuses Moderna's mRNA flu vaccine application, citing inadequate study design, as the company disputes decision, saying it contradicts prior FDA guidance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results